INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Clinical trial / 2005

Formula with DHA and arachidonic acid showed possible neurodevelopmental benefits in larger preterm infants.

In a double-blind randomized comparative study, 27 preterm infants received formula with (n=16) or without (n=11) arachidonic acid (AA) and docosahexaenoic acid (DHA) for 6 months. Mean Mental Development Index scores for supplemented versus non-supplemented groups were 96.1 +/- 8.6 vs 91.7 +/- 10.4 at 6 months and 98.7 +/- 8.0 vs 90.5 +/- 6.9 at 1 year (p = 0.020). Mean Physical Development Index scores were 102.2 +/- 10.5 vs 95.4 +/- 13.2 at 6 months and 98.0 +/- 5.8 vs 86.7 +/- 11.1 at 1 year (p = 0.008). No differences were found in visual acuity, physical examination variables, or vital signs, and no obvious adverse effects occurred.

Study type
Double-blind randomized comparative trial
Who was studied
27 preterm infants (gestational age 30 to 37 weeks, birth weight over 2000 g)
What was measured
Cognitive development, visual acuity, physical examinations, vital signs, adverse events

THE PAPER

The effect of supplementation of docosahexaenoic acid and arachidonic acid on visual acuity and neurodevelopment in larger preterm infants.

Fang PC, Kuo HK, Huang CB, Ko TY, Chen CC, Chung MY. Chang Gung Med J, 2005.

PubMed 16382755 ↗

Nutrients & adequacyBrain & mood

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.